
Journal of International Obstetrics and Gynecology ›› 2026, Vol. 53 ›› Issue (5): 499-504.doi: 10.12280/gjfckx.20260473
• Gynecological Disease & Related Research:Review • Previous Articles Next Articles
Received:2026-05-25
Published:2026-10-15
Online:2026-10-26
Contact:
TANG Liang-dan, E-mail: 201608@hospital.cqmu.edu.cn
PAN Yue, TANG Liang-dan. Research Progress of Ding Kun Dan for Menopausal Symptoms[J]. Journal of International Obstetrics and Gynecology, 2026, 53(5): 499-504.
Add to citation manager EndNote|Ris|BibTeX
| [1] | Chen W, Chen M, Tang H, et al. Advances in diagnosis and treatment of perimenopausal syndrome[J]. Open Life Sci, 2023, 18(1):20220754. doi: 10.1515/biol-2022-0754. |
| [2] |
Hill K. The demography of menopause[J]. Maturitas, 1996, 23(2):113-127. doi: 10.1016/0378-5122(95)00968-x.
pmid: 8735350 |
| [3] | Nappi RE, Chedraui P, Lambrinoudaki I, et al. Menopause: a cardiometabolic transition[J]. Lancet Diabetes Endocrinol, 2022, 10(6):442-456. doi: 10.1016/S2213-8587(22)00076-6. |
| [4] | 中国中西医结合学会妇产科专业委员会. 更年期综合征中西医结合诊治指南(2023年版)[J]. 中国实用妇科与产科杂志, 2023, 39(8):799-808. doi: 10.19538/j.fk2023080109. |
| [5] | 李飞范, 刘金凤. 定坤丹药理作用及妇科临床应用进展[J]. 中国药物经济学, 2025, 20(5):112-117. doi: 10.12010/j.issn.1673-5846.2025.05.024. |
| [6] | 中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南2023版[J]. 中华妇产科杂志, 2023, 58(1):4-21. doi: 10.3760/cma.j.cn112141-20221118-00706. |
| [7] | Panay N, Fenton A, Hamoda H, et al. International Menopause Society (IMS) recommendations and key messages on women's midlife health and menopause[J]. Climacteric, 2025, 28(6):634-656. doi: 10.1080/13697137.2025.2585487. |
| [8] | Su Y, Liu J, Wang Y, et al. Chinese herbal medicine Ding Kun Dan for menopausal syndrome: A systematic review and meta-analysis of randomized controlled trials[J]. Integr Med Res, 2026, 15(2):101254. doi: 10.1016/j.imr.2025.101254. |
| [9] | 李亚荣, 何卫宁. 定坤丹、激素及激素合并定坤丹治疗围绝经期综合征的临床研究[J]. 贵州医药, 2020, 44(12):1886-1888. doi: 10.3969/j.issn.1000-744X.2020.12.018. |
| [10] | 张志刚, 杨军用, 赵新芳, 等. 蔡钢教授治疗围绝经期综合征的临床经验[J]. 临床医学研究与实践, 2020, 5(12):125-126. doi: 10.19347/j.cnki.2096-1413.202012049. |
| [11] | 陈金水. 中医学[M]. 9版. 北京: 人民卫生出版社, 2018. |
| [12] | Dou XX, Cai YL, Xu XK, et al. In vivo and in vitro metabolism study of traditional Chinese medicine formula Dingkun Dan in rats by using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry[J]. Biomed Chromatogr, 2022, 36(1):e5235. doi: 10.1002/bmc.5235. |
| [13] | Moratalla-López N, Bagur MJ, Lorenzo C, et al. Bioactivity and Bioavailability of the Major Metabolites of Crocus sativus L. Flower[J]. Molecules, 2019, 24(15):2827. doi: 10.3390/molecules24152827. |
| [14] |
Wu W, Sun L, Zhang Z, et al. Profiling and multivariate statistical analysis of Panax ginseng based on ultra-high-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry[J]. J Pharm Biomed Anal, 2015, 107:141-150. doi: 10.1016/j.jpba.2014.12.030.
pmid: 25590943 |
| [15] | 张涛, 张斌, 王佩义, 等. 定坤丹组方药物化学成分与药理作用研究进展[J]. 神经药理学报, 2015, 5(6):40-50. doi: 10.3969/j.issn.2095-1396.2015.06.007. |
| [16] | Ma K, Chen Y, Fan X, et al. Dingkun Pill replenishes diminished ovarian reserve through the PI3K/AKT/mTOR signaling pathway in TWP-induced mice[J]. J Ethnopharmacol, 2020, 262:112993. doi: 10.1016/j.jep.2020.112993. |
| [17] | Su C, Zhang R, Zhang X, et al. Dingkun Pill modulate ovarian function in chemotherapy-induced premature ovarian insufficiency mice by regulating PTEN/PI3K/AKT/FOXO3a signaling pathway[J]. J Ethnopharmacol, 2023, 315:116703. doi: 10.1016/j.jep.2023.116703. |
| [18] | Chen L, Yan X, Lian Y, et al. Dingkun Pill-Mediated TGF-β1/Smad2 Pathway Effects on Granulosa Cell Proliferation and Apoptosis[J]. Mol Biotechnol, 2026, 68(3):1299-1307. doi: 10.1007/s12033-025-01439-z. |
| [19] |
Huang L, Wang L, Bao H, et al. Traditional Chinese medicine Dingkun Pill facilitates uterine receptivity for implantation in mice[J]. Biol Reprod, 2019, 101(4):695-703. doi: 10.1093/biolre/ioz141.
pmid: 31347662 |
| [20] | Ding X, Deng Y, Wang Y, et al. Serum metabolomic profiling reveals potential biomarkers in assessing the management of women with polycystic ovary syndrome: a randomized controlled trial[J]. Chin Med J(Engl), 2022, 135(1):79-85. doi: 10.1097/CM9.0000000000001705. |
| [21] |
Gu M, Cai H, Deng W, et al. Dingkun pill alleviates metabolic abnormalities in polycystic ovary syndrome through brown adipose tissue activation[J]. J Ovarian Res, 2023, 16(1):176. doi: 10.1186/s13048-023-01215-0.
pmid: 37633943 |
| [22] | Cai YL, Zhang F, Dou XX, et al. Integrated metabolomics and network pharmacology to reveal the therapeutic mechanism of Dingkun Pill on polycystic ovary syndrome[J]. J Ethnopharmacol, 2022, 295:115442. doi: 10.1016/j.jep.2022.115442. |
| [23] |
Hao K, Gong P, Sun SQ, et al. Beneficial estrogen-like effects of ginsenoside Rb1, an active component of Panax ginseng, on neural 5-HT disposition and behavioral tasks in ovariectomized mice[J]. Eur J Pharmacol, 2011, 659(1):15-25. doi: 10.1016/j.ejphar.2011.03.005.
pmid: 21414307 |
| [24] |
Zhou P, Deng F, Yang Z, et al. Ginsenoside Rb1 inhibits oxidative stress-induced ovarian granulosa cell injury through Akt-FoxO1 interaction[J]. Sci China Life Sci, 2022, 65(11):2301-2315. doi: 10.1007/s11427-021-2080-x.
pmid: 35661967 |
| [25] | 邵芳. 定坤丹对围绝经综合征患者中医证候、内分泌激素水平的影响[J]. 内蒙古中医药, 2023, 42(10):19-20. doi: 10.16040/j.cnki.cn15-1101.2023.10.034. |
| [26] | 璩丽燕, 祝萍, 周剑. 定坤丹联合戊酸雌二醇对围绝经综合征妇女激素水平和心理状态的影响[J]. 当代医学, 2020, 26(20):10-12. doi: 10.3969/j.issn.1009-4393.2020.20.004. |
| [27] | 曾芳. 定坤丹联合克龄蒙治疗围绝经期综合征对性激素和血脂代谢指标的影响[J]. 黑龙江医药, 2023, 36(4):783-786. doi: 10.14035/j.cnki.hljyy.2023.04.012. |
| [28] | 朱显琴, 彭志伟, 王惠琳. 定坤丹联合雌二醇片/雌二醇地屈孕酮片复合包装激素补充疗法治疗围绝经期综合征的效果及对神经递质、骨代谢水平的影响[J]. 临床医学研究与实践, 2023, 8(34):112-115,136. doi: 10.19347/j.cnki.2096-1413.202334026. |
| [29] | 陈淑敏, 董黎. 定坤丹联合替勃龙治疗围绝经期综合征的临床研究[J]. 现代药物与临床, 2020, 35(9):1886-1890. doi: 10.7501/j.issn.1674-5515.2020.09.034. |
| [30] | 李丽君, 陈雪梅, 罗素琴, 等. 绝经激素治疗联合定坤丹在围绝经期综合征中的应用[J]. 中国当代医药, 2022, 29(24):69-72. doi: 10.3969/j.issn.1674-4721.2022.24.018. |
| [31] | 吴洁, 代彦娥. 定坤丹联合雌二醇片/雌二醇地屈孕酮片复合包装治疗围绝经期综合征的临床效果[J]. 临床医学研究与实践, 2025, 10(17):93-96. doi: 10.19347/j.cnki.2096-1413.202517023. |
| [32] | 葛玉玲. 定坤丹治疗女性绝经综合征的疗效评价[J]. 实用妇科内分泌电子杂志, 2021, 8(30):13-15. doi:10.3969/j.issn.2095-8803.2021.30.005. |
| [1] | GUO Xi, WEI Jia, YANG Yong-xiu. Hormonal Pathways and Regulatory Factors That Lead to Endometrial Disease [J]. Journal of International Obstetrics and Gynecology, 2024, 51(4): 395-400. |
| [2] | HE Fei, ZHOU Jian-hong, CHU Ke-tan. The Research Progress on Related Risk Factors and Treatment of Sleep Disorders in Perimenopausal and Postmenopausal Women [J]. Journal of International Obstetrics and Gynecology, 2024, 51(4): 412-416. |
| [3] | LIU Xiang, AO Kai, GAO Yi-wei, WU Qiong, MU Yu-lan. Effects of Vitamin E on the Health of Perimenopausal and Postmenopausal Women [J]. Journal of International Obstetrics and Gynecology, 2024, 51(1): 93-98. |
| [4] | HE Tian-yu, WANG Fang. Genetic Polymorphisms and Recurrent Spontaneous Abortion [J]. Journal of International Obstetrics and Gynecology, 2023, 50(1): 82-87. |
| [5] | WANG Xiao-xue, YANG Mu-kun, BAI Wen-pei. Unique Factors in Female Bronchial Asthma: Menopause? Hormone Therapy? [J]. Journal of International Obstetrics and Gynecology, 2022, 49(4): 456-460. |
| [6] | WANG Yuan-yuan, HUANG Yi-zhou, XU Ling. Research Progress of Homocysteine in Cardiovascular Diseases in Postmenopausal Women [J]. Journal of International Obstetrics and Gynecology, 2021, 48(4): 429-433. |
| [7] | XU Qian, LIU Bin, WANG Dao-juan, WANG Yong. The Central Mechanism of Endocrine Disorder Induced by Androgen in PCOS Patients [J]. Journal of International Obstetrics and Gynecology, 2021, 48(2): 203-208. |
| [8] | ZHOU Lin-zhi, CHEN Xiu-hui, KONG Xian-chao. The Intracrinology and Targeted Therapy of Endometrial Cancer [J]. Journal of International Obstetrics and Gynecology, 2020, 47(6): 632-636. |
| [9] | LIU Yan, CHENG Rui, SUN Ruo-yun, MA Rui-hong, XIA Tian. Different Degrees of Psychological Stress on Stress Hormone Level of HPA Axis and Ovarian Reserve Function in Mice [J]. Journal of International Obstetrics and Gynecology, 2020, 47(3): 311-314. |
| [10] | DU Yi-ni, WANG Xue, CHEN Yi-Jie, JIA Cen-lin, HUANG Jian, JIN Xue-jing, ZHANG Zhi-fen. Effect of Follicle-Stimulating Hormone on Peri-Menopausal Osteoporosis and Its Mechanism [J]. Journal of International Obstetrics and Gynecology, 2020, 47(3): 297-300. |
| [11] | HUANG Zhi-ying, DING Yan. Advances in Research on Metabolic Syndrome in Perimenopausal Women [J]. Journal of International Obstetrics and Gynecology, 2020, 47(1): 84-87. |
| [12] | CHEN Xing;ZHOU Ying-fang;BAI Wen-pei. Research Progress of the Risk of Tumors of Menopausal Hormone Replacement Therapy [J]. Journal of International Obstetrics and Gynecology, 2016, 43(5): 489-492. |
| [13] | DU Xiao-qin;HENG Ming-li;XU Ling. Meta Analysis of Efficacy and Safety between Kuntai Capsule and Hormone Replacement Therapy for Patients with Perimenopausal Syndrome [J]. Journal of International Obstetrics and Gynecology, 2016, 43(3): 267-271. |
| [14] | DU Xiao-qin;HENG Ming-li;XU Ling. Meta Analysis of Efficacy and Safety between Kuntai Capsule and Hormone Replacement Therapy for Patients with Perimenopausal Syndrome [J]. Journal of International Obstetrics and Gynecology, 2016, 43(3): 267-271. |
| [15] | CHEN Ying. The Relationship between Age, Menopausal Status and Homocysteine Level [J]. Journal of International Obstetrics and Gynecology, 2015, 42(2): 191-193. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
